Cancer systems immunology | eLife
Alternative molecular formats and therapeutic applications for bispecific antibodies - ScienceDirect
Therapeutic antibodies for autoimmunity and inflammation | Nature Reviews Immunology
Microfluidic single-cell technology in immunology and antibody screening - ScienceDirect
Lymph node choreography: B cells take the lead | Nature Immunology
PDF) Techniques to Study Antigen-Specific B Cell Responses
Cancer systems immunology | eLife
PDF) Therapeutic antibodies for autoimmunity and inflammation
Microfluidic single-cell technology in immunology and antibody screening - ScienceDirect
Preferential Presentation of High-Affinity Immune Complexes in Germinal Centers Can Explain How Passive Immunization Improves the Humoral Response - ScienceDirect
Frontiers | Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance | Immunology
Post‐transcriptional control of immune responses and its potential application - Yoshinaga - 2019 - Clinical & Translational Immunology - Wiley Online Library
Antibody-dependent fragmentation is a newly identified mechanism of cell killing in vivo | Scientific Reports
Vaccine candidate discovery for the next generation of malaria vaccines - Tuju - 2017 - Immunology - Wiley Online Library
mRNA as novel technology for passive immunotherapy | SpringerLink
mRNA as novel technology for passive immunotherapy | SpringerLink
Preferential Presentation of High-Affinity Immune Complexes in Germinal Centers Can Explain How Passive Immunization Improves the Humoral Response - ScienceDirect
Microfluidic single-cell technology in immunology and antibody screening - ScienceDirect
Table of contents : Nature Reviews Immunology Focus on Therapeutic antibodies
Targeting cytokines in disease | Nature Immunology
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning | Nature Reviews Immunology
RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease | Molecular Pharmacology
mRNA as novel technology for passive immunotherapy | SpringerLink
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization | Nature Biotechnology
